SMAD9 and cardiovascular disorder: This is of particular relevance with regard to the established importance of loss of BMPR2 and other receptors in cardiovascular disease: mutations in BMP receptor II (BMPR2)50 and in the BMP co-receptor endoglin or the receptor activated SMAD9 result in reduced BMP signalling and primary pulmonary hypertension13, 51.